This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Sanofi Pasteur Inc. as the prime contractor. The IDC has a ceiling value of $6,294,039,491.48 and a period of performance through May 30, 2026.
The purpose of the IDC is to facilitate the development and domestic manufacture of adjuvanted, pandemic influenza vaccines to support public health preparedness and response capabilities. Sanofi Pasteur, as a manufacturer of pharmaceuticals, medical supplies, and vaccines, will provide these products and related services to ASPR and potentially other federal agencies through task orders issued under the IDC. The contract does not have any set-aside designations and was awarded on a single-award basis. Work will be performed primarily at Sanofi Pasteur's facility in Swiftwater, Pennsylvania. This IDC leverages Sanofi Pasteur's existing manufacturing, distribution, and immunization expertise to efficiently fulfill federal agency requirements for critical vaccines and pharmaceuticals.
Generated 12/13/24, 9:08 AM